Organic Active Ingredients TRIZ Cases

Enteric coated 5-aminolevulinic acid targets the colon, reducing systemic exposure and adverse effects while maintaining anti-inflammatory efficacy.

Selective adenosine A2a antagonists block receptor signaling to restore cytotoxic T-cell activity in cancer therapy.

Crystalline forms of the isoquinoline derivative resolve stability contradictions via parameter changes, ensuring reliable drug efficacy.

Targeted thrA gene edits overcome low lysine yields in wildtype E. coli, enabling high-titer production.

Preliminary HEC1, Rb, and p53 profiling identifies patients responsive to HEC1 inhibitors, avoiding ineffective treatment.

Magnetic polarization aligns molecular dipoles in dilute scorpion venom, resolving the contradiction between therapeutic effectiveness and toxic side effects.

Networking hyaluronan with polyolefin copolymers yields hydrogels that maintain shape and integrity while swollen in aqueous solvents.

Novel oxadiazole carboxamide compounds promote parasite tubulin polymerization to disrupt microtubule dynamics and inhibit cell division.

2-Arylbenzimidazole compounds activate the Ppargc1a protein to treat neurodegenerative diseases.

Inhibiting thymine DNA glycosylase overcomes resistance and reduces toxicity by enhancing tumor cell sensitivity to gemcitabine.

A NAMPT-targeting degrader uses PROTAC technology to induce intracellular protein degradation.

Menaquinone-n feed supplement replaces probiotics to improve weight gain and reduce mortality.

Reverse enteric polymer and antacid coating inhibits drug release in gastric fluids when multiple units are ingested, suppressing peak plasma levels.

Developing crystalline hydrochloride, sulfate, and solvate forms of AMG 397 improves stability and bioavailability while managing manufacturing complexity.

A collagen sol gels in the submucosa to maintain mucosal elevation height during endoscopic procedures.

Sequential EGFR inhibitor administration unmasks apoptotic processes via caspase-8 activation, overcoming drug resistance in triple-negative breast cancers.

Segmented anticoagulation and treatment fluids with adjusted citrate and bicarbonate levels resolve acid-base balance trade-offs across varying flow rates.

A Streptococcus infantis composition strengthens skin barrier function and enhances elasticity through microbial activity.

Eriocitrin compositions increase GLP-1 levels via DPP4 inhibition, managing glycemic control without synthetic drug side effects.

AMH administration stabilizes follicle development and increases oocyte yield while avoiding follicular arrest in diminished ovarian reserve.

Light-accepting molecules amplify ultra-weak photon emission intensity, resolving detection sensitivity limits for non-invasive metabolic monitoring.

A surfactant-free solid pharmaceutical composition uses optimized particle size and disintegrants to enhance drug solubility.

Diels-Alder cross-linking eliminates toxic catalysts, enabling safe in situ gelation for drug delivery.

Formula I organic compounds selectively activate adenosine A2A receptors to reduce airways inflammation and bronchial hyperreactivity.

Replacing toxic chlorinated hydrocarbons, N-alkyl lactam ethers maintain grease-cutting performance while eliminating safety hazards.

Developing novel remdesivir salts like napsylate and tosylate overcomes poor aqueous chemical stability, enabling oral administration.

Formula IA and IB compounds use defined heteroaromatic substitution patterns to achieve selective inhibition of the human α1β3γ2 receptor subtype.

Substituted imidazole compounds selectively bind Factor Xa, resolving the trade-off between selective inhibition and bioavailability.

Co-administering HDAC inhibitors with immunomodulatory drugs increases interferon-regulated gene expression in cancer cells.

Merges SEMA4D blockade with HTT reduction to address insufficient efficacy of single-agent therapies in Huntington's disease.

Co-administering mRNA encoding hyaluronidase degrades extracellular matrices to overcome size barriers and improve subcutaneous delivery efficiency.

Targeting ATM-deficient tumor cells with STING antagonists improves treatment efficacy.

Antioxidant pre-treatment enhances stem cell regenerative potential and survival in chronic disease therapy.

N-methylspermidine resists oxidation to maintain stability and efficacy in treating excessive hair loss.

Crystalline diazabicyclooctane derivatives inhibit beta-lactamases to restore antibiotic efficacy.

Iontophoretic delivery system circulates therapeutic solution within the nasal cavity to maintain ion concentration during electrical current application.

Soluble solid dispersion rifaximin formulation overcomes poor bioavailability to reduce mortality in hepatic encephalopathy patients.

Deactivated Cas9 guided by RNA impedes transcription elongation at expanded microsatellite repeats, reducing toxic RNA production in myotonic dystrophy models.

Extending continuous hormone exposure to at least 120 days suppresses withdrawal and intermenstrual bleeding while maintaining contraceptive reliability.

Resolve proliferation-passaging contradictions in human hepatocyte induction by applying histone deacetylase inhibitors to enhance plasticity.

A self-emulsifiable phospholipid composition produces nanoemulsions through spontaneous mixing with aqueous solutions.

Nucleic acid molecules encoding HLA-H proteins enable targeted immunosuppressive and tumor vaccine applications.

Pre-, concurrent, and post-administration hyperthermia maintains tumor temperatures between 38°C and 45°C to optimize drug uptake.

Segmented chambers preserve shelf-life while a sliding valve ensures reliable mixing consistency during emergency delivery.

Film matrix with stabilizers masks bitter taste and prevents degradation, improving compliance for patients.

Eritoran blocks TLR4 receptors to reduce inflammatory cytokine levels and improve survival rates in Ebola and Marburg virus infections.

Aminopyridine compounds target LRRK2 phosphorylation sites to halt dopaminergic neuron loss, avoiding adverse side effects of symptomatic dopamine therapies.

MAP1B polypeptides bind PCA-2-specific autoantibodies to form detectable complexes, resolving limited diagnostic capability for paraneoplastic disorders.

Removing the buffer system prevents corticosteroid degradation during manufacturing, ensuring long-term efficacy and extended shelf life.

A dual syringe formatting system mixes calcium sulfate and antibiotics into a sterile paste via luer lock connection.

Scutellarin blocks the TNF-TNFR2 interaction to selectively inhibit regulatory T cell proliferation.

Segmented mini-tablets mask bitter taste via food vehicles to improve swallowability and compliance.

Braftide binds the BRAF kinase dimer interface to disrupt protein interactions, preventing paradoxical activation in wild-type BRAF tumors.

Antisense oligomers hybridize with mutated ATM sequences to restore wild-type splicing and correct aberrant splicing in Ataxia Telangiectasia.

Novel tetrahydropyridopyrimidines inhibit HBV replication and antigen production.

Formula I compounds block bacterial efflux pumps, lowering the minimum inhibitory concentration required for antibiotics to treat resistant infections.

Crystalline Form B hydrochloride salt achieves chemical stability and mitigates pH effects while maintaining sufficient solubility for further processing.

Lipid medium formulation with surfactants creates self-emulsifying soft gelatin capsules for oral delivery.

Segmented delivery of nicotinic acid modifies intestinal microbiota to improve blood lipid profiles while minimizing systemic side effects.

Opioid agonist peptides inhibit gastrointestinal motility via mu or delta receptor activation, reducing pain without ischemic colitis risk.

Formula I pyridopyrimidinone compounds modulate histone lysine demethylase catalytic activity to address the lack of potent inhibitors.

Repetitive administration of an unmethylated CG dinucleotide oligonucleotide induces stable remission, reducing the need for colectomy in refractory patients.

A teat seal formulation uses a lower alkyl vinyl ether-maleic anhydride copolymer in a gel base to form a bio-adhesive physical barrier.

Integrated applicator pad delivers medication and applies pressure via a grip to enhance hemostasis for minor wounds.

A tamper-resistant soft capsule utilizes a lipid and organogelator matrix to control active ingredient release rates.

Removing valine from the diet selectively suppresses ATL cell proliferation while preserving normal blood parameters.

Segmented microneedles inject bioactive compounds into the dermis, bypassing gastrointestinal filtration to preserve biological activity.

Novel catechol derivative activates autophagy via mTOR inhibition to treat liver fibrosis where conventional therapies lack efficacy.

Amyloid beta compounds deactivate hepatic stellate cells and restore liver endothelial permeability to treat fibrosis.

An aqueous dispersion of anionized nanocellulose prevents peritoneal adhesions across the entire cavity, reducing adhesive intestinal obstruction risk.

Fused tricyclic ring derivatives inhibit Src Homology-2 phosphatase to overcome resistance against MAPK pathway targeted drugs.

Direct submucous injection retains nucleic acids without carriers, eliminating immune responses and extending therapeutic duration.

Intranasal metoclopramide formulations deliver targeted relief for nausea and abdominal pain in diabetic gastroparesis patients.

Benzimidazole-based inhibitor targets TTX-resistant sodium channels to treat neuropathic pain without central nervous system side effects.

A 3,4-dihydroquinazoline derivative blocks T-type calcium channels to inhibit intracellular calcium influx in cancer cells.

A catalytic intramolecular allyl amination method using iridium-phosphoramidite complexes to synthesize chiral pyrimidine-fused diazepinone derivatives.

A herbal composition reduces oxidative stress through synergistic antioxidant activity.

Self-assembled cobalt complexes with body-derived ligands provide non-toxic antibacterial action, replacing toxic copper ions.

Indazole sulfonamides inhibit KasA enzyme, countering drug resistance and enabling shorter tuberculosis regimens.

Fucosylated oligosaccharides modulate immune responses to prevent bronchitis and ear infections, minimizing antibiotic use.

A pharmaceutical composition combining N-acetylcysteine, hyaluronic acid, and Vitamin C to protect oropharyngeal mucous membranes.

Quadruplex-forming guanosine-rich oligonucleotides stabilize specific molecular structures to inhibit cellular proliferation and induce cell death.

Atractylenolide I combined with a P2X7R antagonist inhibits cervical cancer cell proliferation through synergistic receptor activation.

Optimized hydroalcoholic paracetamol concentrations resolve stability and intolerance trade-offs to accelerate drug passage through the blood-brain barrier.

Phosphoglycerate kinase 1 expression analysis identifies peritoneal carcinosis and predicts metastasis from primary gastrointestinal tumors.

Formula I heterocyclic compounds inhibit glutaminase 1 activity to disrupt cancer cell metabolism.

Sibiriline derivatives stabilize RIPK1 inhibition by modifying metabolic stability and reducing off-target effects compared to existing inhibitors.

7-Azaindazole compounds antagonize Wnt pathway signaling, addressing the lack of effective inhibitors for genetic and proliferative diseases.

An artificial exosome complex fuses linear polyethyleneimine and hyaluronic acid to deliver active substances into deep skin layers.

CIP2b in PLGA nanoparticles inhibits P-gp to increase paclitaxel accumulation, reducing adverse events from high doses.